
European Medicines Agency Begins Review of First Human Lyme Disease Vaccine
A significant step has been taken in the fight against Lyme disease as the European Medicines Agency (EMA) begins evaluating the application for a vaccine candidate developed by Pfizer and Valneva, which could become the first human vaccine against the disease in Europe if approved.






